Virtual Addiction Treatment Providers Go Brick-and-Mortar with DEA Changes Looming - Behavioral Health Business
Virtual addiction treatment providers are opening physical clinics in anticipation of DEA rule changes that may restrict telemedicine prescribing of controlled substances. This shift suggests the DEA may tighten requirements, potentially requiring in-person visits or limiting cross-state prescribing.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Before DEA final rule expected in late 2024 or early 2025.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA is expected to finalize rules that could require in-person visits for controlled substance prescribing, reversing pandemic-era flexibilities. Providers are preemptively establishing brick-and-mortar locations.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers
What you must do
Review current telemedicine prescribing practices for controlled substances and prepare for potential in-person visit requirements or special registration.
Deadline
Before DEA final rule expected in late 2024 or early 2025.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances - MedPage Today
- DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain - McDermott+
- DEA Extends Telemedicine Flexibilities for Ketamine Prescribing: What Clinics Need to Know in 2026 - JD Supra
- Georgia medical board will limit virtual prescriptions - Atlanta Journal-Constitution
- DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis